menu
    • menu

    Company profile for Puma Biotechnology

    NEW Drugs in Dev: 5
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We focus on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then seek to further develop these drug candidates for commercial use.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Puma BiotechnologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    10880 Wilshire Blvd., Suite 2150 Los Angeles, CA 90024
    Telephone
    Telephone
    424-248-6500
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.pumabiotechnology.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/puma-biotechnology-ltd
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ICMD China

    ICMD China

    Not Confirmed

    envelop Contact Supplier

    ICMD China

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Puma Bio Reports Inducement Awards Under Nasdaq LR 5635(c)(4)
    Puma Bio Reports Inducement Awards Under Nasdaq LR 5635(c)(4)

    02 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260402834243/en/Puma-Biotechnology-Reports-Inducement-Awards-Under-Nasdaq-Listing-Rule-5635c4

    BUSINESSWIRE
    02 Apr 2026
    Share Share
    Puma Biotech Presents at TD Cowen's 46th Health Care Conference
    Puma Biotech Presents at TD Cowen's 46th Health Care Conference

    23 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260223106044/en/Puma-Biotechnology-to-Present-at-TD-Cowens-46th-Annual-Health-Care-Conference

    BUSINESSWIRE
    23 Feb 2026
    Share Share
    Puma Bio To Host Conference On Q4 & Full Year 2025 Finances
    Puma Bio To Host Conference On Q4 & Full Year 2025 Finances

    12 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260212152131/en/Puma-Biotechnology-to-Host-Conference-Call-to-Discuss-Fourth-Quarter-and-Full-Year-2025-Financial-Results

    BUSINESSWIRE
    12 Feb 2026
    Share Share
    Puma Bio Discloses Inducement Awards Per Nasdaq LR 5635(C)(4)
    Puma Bio Discloses Inducement Awards Per Nasdaq LR 5635(C)(4)

    05 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-05/puma-biotechnology-reports-inducement-awards-under-nasdaq-listing-rule-5635-c-4

    PHARMIWEB
    05 Feb 2026
    Share Share
    Puma Bio Discloses Inducement Awards Per Nasdaq LR 5635(C)(4)
    Puma Bio Discloses Inducement Awards Per Nasdaq LR 5635(C)(4)

    04 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260204668424/en/Puma-Biotechnology-Reports-Inducement-Awards-Under-Nasdaq-Listing-Rule-5635c4

    BUSINESSWIRE
    04 Feb 2026
    Share Share
    Puma Bio Discloses Inducement Awards Per Nasdaq LR 5635(C)(4)
    Puma Bio Discloses Inducement Awards Per Nasdaq LR 5635(C)(4)

    07 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260107619991/en/Puma-Biotechnology-Reports-Inducement-Awards-Under-Nasdaq-Listing-Rule-5635c4

    BUSINESSWIRE
    07 Jan 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search